Researchers have introduced data revealing how sufferers with metastatic breast most cancers develop resistance to the therapy Enhertu (trastuzumab deruxtecan, T-DXd) in...
This years 2026 ASCO Gastrointestinal Cancers Symposium was full of practice-shaping knowledge throughout colorectal and higher gastrointestinal malignancies, in line with Dr....
Researchers from the Dana-Farber Most cancers Institute and worldwide analysis teams have revealed information in The New England Journal of Drugs exhibiting...
In an interview with CURE, Dr. Elias Obeid, a medical oncologist at Hackensack College Medical Middle, mentioned the significance of threat evaluation...
